| For: | Inno A, Fanetti G, Bartolomeo MD, Gori S, Maggi C, Cirillo M, Iacovelli R, Nichetti F, Martinetti A, Braud F, Bossi I, Pietrantonio F. Role of MGMT as biomarker in colorectal cancer. World J Clin Cases 2014; 2(12): 835-839 [PMID: 25516857 DOI: 10.12998/wjcc.v2.i12.835] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v2/i12/835.htm |
| Number | Citing Articles |
| 1 |
Dan Gao, James G. Herman, Mingzhou Guo. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer. Oncotarget 2016; 7(24) doi: 10.18632/oncotarget.7949
|
| 2 |
Pramod K Julka, Deepika Arya, Afnan Bhasir, Sanjay Gupta. O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation-Guided Irinotecan-Based Therapy in Metastatic Colorectal Cancer: A Case Report. Cureus 2026; doi: 10.7759/cureus.113070
|
| 3 |
Latha M. Malaiyandi, Lawrence A. Potempa, Nicholas Marschalk, Paiboon Jungsuwadee, Kirk E. Dineley. Apoptosis and Beyond. 2018; doi: 10.1002/9781119432463.ch21
|
| 4 |
Zoran Gatalica, Semir Vranic, Joanne Xiu, Jeffrey Swensen, Sandeep Reddy. High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine. Familial Cancer 2016; 15(3) doi: 10.1007/s10689-016-9884-6
|
| 5 |
Zachary D. Nagel, Andrew A. Beharry, Patrizia Mazzucato, Gaspar J. Kitange, Jann N. Sarkaria, Eric T. Kool, Leona D. Samson, Brendan D Price. Fluorescent reporter assays provide direct, accurate, quantitative measurements of MGMT status in human cells. PLOS ONE 2019; 14(2) doi: 10.1371/journal.pone.0208341
|
| 6 |
Michele Ghidini, Nicola Fusco, Massimiliano Salati, Shelize Khakoo, Gianluca Tomasello, Fausto Petrelli, Dario Trapani, Angelica Petrillo. The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy. Current Drug Targets 2021; 22(9) doi: 10.2174/1389450122666210204204415
|
| 7 |
Alexander V. Sergeev, Daniil P. Malyshev, Adelya I. Genatullina, Galina V. Pavlova, Elizaveta S. Gromova, Maria I. Zvereva. Single-Molecule Nanopore Sequencing of the CpG Island from the Promoter of O6-Methylguanine-DNA Methyltransferase Provides Insights into the Mechanism of De Novo Methylation of G/C-Rich Regions. Epigenomes 2025; 9(1) doi: 10.3390/epigenomes9010004
|
| 8 |
Maha M. Elbrashy, Sally Farouk, Nadia M. Hamdy, Hozaifa Metwally, Noha G. Bader El Din. From (Epi)genetics-to-Precision (E2P). Subcellular Biochemistry 2026; 114 doi: 10.1007/978-3-032-08530-6_4
|
| 9 |
L. Barault, A. Amatu, F.E. Bleeker, C. Moutinho, C. Falcomatà, V. Fiano, A. Cassingena, G. Siravegna, M. Milione, P. Cassoni, F. De Braud, R. Rudà, R. Soffietti, T. Venesio, A. Bardelli, P. Wesseling, P. de Witt Hamer, F. Pietrantonio, S. Siena, M. Esteller, A. Sartore-Bianchi, F. Di Nicolantonio. Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. Annals of Oncology 2015; 26(9) doi: 10.1093/annonc/mdv272
|
| 10 |
Julia Krushkal, Simarjeet Negi, Laura M. Yee, Jason R. Evans, Tanja Grkovic, Alida Palmisano, Jianwen Fang, Hari Sankaran, Lisa M. McShane, Yingdong Zhao, Barry R. O'Keefe. Molecular genomic features associated with in vitro response of the NCI‐60 cancer cell line panel to natural products. Molecular Oncology 2021; 15(2) doi: 10.1002/1878-0261.12849
|
| 11 |
Khatere Mokhtari, Maryam Peymani, Mohsen Rashidi, Kiavash Hushmandi, Kamran Ghaedi, Afshin Taheriazam, Mehrdad Hashemi. Colon cancer transcriptome. Progress in Biophysics and Molecular Biology 2023; doi: 10.1016/j.pbiomolbio.2023.04.002
|
| 12 |
Jiyu Tang, Xiaoming Shi, Chao Song, Wenjing Zhang, Yan Yan, Linchao Dai, Di Wu, Jie Qiu, Jiahuan Liu, Tao Wang, Zuhong Lu. DNA methylation in esophageal cancer: technological advances and early detection clinical applications. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1543190
|
| 13 |
Riccardo Ricci, Maurizio Martini, Gloria Ravegnini, Tonia Cenci, Massimo Milione, Paola Lanza, Francesco Pierconti, Donatella Santini, Sabrina Angelini, Alberto Biondi, Fausto Rosa, Sergio Alfieri, Gennaro Clemente, Roberto Persiani, Alessandra Cassano, Maria A. Pantaleo, Luigi M. Larocca. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-018-0594-9
|
| 14 |
Filippo Pietrantonio, Giovanni Randon, Dario Romagnoli, Samantha Di Donato, Matteo Benelli, Filippo de Braud. Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer. Cancer Treatment Reviews 2020; 82 doi: 10.1016/j.ctrv.2019.101935
|
| 15 |
Siqi Fu, Haijing Wu, Huiming Zhang, Christine G. Lian, Qianjin Lu. DNA methylation/hydroxymethylation in melanoma. Oncotarget 2017; 8(44) doi: 10.18632/oncotarget.18293
|
| 16 |
Csaba T�th, Farkas S�k�sd, Erzs�bet Valicsek, Esther Herpel, Peter Schirmacher, L�szl� Tiszlavicz. Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.7756
|
| 17 |
Yue Zhao, Fei Feng, Qing-Hong Guo, Yu-Ping Wang, Rui Zhao. Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors. World Journal of Gastroenterology 2020; 26(34): 5074-5089 doi: 10.3748/wjg.v26.i34.5074
|
| 18 |
Barbara Pasculli, Raffaela Barbano, Paola Parrella. Epigenetic Mechanisms in Cancer. 2018; doi: 10.1016/B978-0-12-809552-2.00011-5
|
| 19 |
Sandra Mersakova, Katarina Janikova, Michal Kalman, Juraj Marcinek, Marian Grendar, Martin Vojtko, Roman Kycina, Miroslav Pindura, Jan Janik, Peter Mikolajcik, Eva Gabonova, Ludovit Laca, Ester Mejstrikova, Erika Halasova, Jan Strnadel, Zora Lasabova. Cancer stem cell marker expression and methylation status in patients with colorectal cancer. Oncology Letters 2022; 24(1) doi: 10.3892/ol.2022.13352
|
| 20 |
Lizhen Chen, Alex Wen. Unveiling the role of O(6)-methylguanine-DNA methyltransferase in cancer therapy: insights into alkylators, pharmacogenomics, and others. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1424797
|
| 21 |
Filippo Pietrantonio, Filippo de Braud, Massimo Milione, Claudia Maggi, Roberto Iacovelli, Katia Fiorella Dotti, Federica Perrone, Elena Tamborini, Marta Caporale, Rosa Berenato, Giorgia Leone, Alessio Pellegrinelli, Ilaria Bossi, Fabrizio Festinese, Stefano Federici, Maria Di Bartolomeo. Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer. Targeted Oncology 2016; 11(3) doi: 10.1007/s11523-015-0397-2
|
| 22 |
M A Calegari, A Inno, S Monterisi, A Orlandi, D Santini, M Basso, A Cassano, M Martini, T Cenci, I de Pascalis, F Camarda, B Barbaro, L M Larocca, S Gori, G Tonini, C Barone. A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation. British Journal of Cancer 2017; 116(10) doi: 10.1038/bjc.2017.109
|
| 23 |
Zhengdong Yang, Xinyang Wang, Huiying Zhou, Minghan Jiang, Jinghui Wang, Bowen Sui. Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies. Cancer Management and Research 2024; doi: 10.2147/CMAR.S481656
|
| 24 |
Shivani Prasad, Amlan Pati, Soumyaranjan Panda, Sanjay Saxena. Radiomics and Radiogenomics in Neuro-Oncology. 2025; doi: 10.1016/B978-0-443-18509-0.00003-7
|
| 25 |
Supistha Sontidejkul, Pornpimol Phuengmaung, Wilasinee Saisorn, Warerat Kaewduangduen, Kent Doi, Atsadang Boonmee, Salisa Benjaskulluecha, Tanapat Palaga, Asada Leelahavanichkul. Prominent fibroblast growth factor 21 with less abundant tumor-associated macrophages in hepatic mass of the conditional mgmt-deleted mice using LysM-Cre system. Inflammation Research 2025; 74(1) doi: 10.1007/s00011-025-02077-6
|
| 26 |
Sepideh Shahkarami, Samaneh Zoghi, Nima Rezaei. Cancer Immunology. 2020; doi: 10.1007/978-3-030-30845-2_22
|
| 27 |
Ningning Zhao, Chuanxi Lai, Yunfei Wang, Sheng Dai, Hongcang Gu. Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(3) doi: 10.1016/j.bbcan.2024.189096
|
| 28 |
Érica S. S. de Araújo, Dimitrius T. Pramio, André Y. Kashiwabara, Paula C. Pennacchi, Silvya S. Maria-Engler, Maria I. Achatz, Antonio H. J. F. M. Campos, João P. Duprat, Carla Rosenberg, Dirce M. Carraro, Ana C. V. Krepischi. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients. BioMed Research International 2015; 2015 doi: 10.1155/2015/376423
|
| 29 |
Giuseppina Improta, Cathrin Ritter, Angela Pettinato, Valeria Vasta, David Schrama, Filippo Fraggetta, Jürgen C. Becker. MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo. Journal of Cancer Research and Clinical Oncology 2017; 143(8) doi: 10.1007/s00432-017-2413-7
|